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Insulinomas, although rare, are the 
most common functional pancreatic 
neuroendocrine tumors (PNET).1 These 
tumors are thought to derive from beta 
cells which ectopically produce insulin. 
Symptoms are generally related to the 
overproduction of insulin resulting in 
hypoglycemic episodes. The hallmark of 
this syndrome is the failure of suppression 
of endogenous insulin section during 
periods of low serum blood sugars (often 
during fasting states).2 Thus, the diagnosis 
is often made biochemically. Conventional 
imaging with computed tomography or 
trans-abdominal ultrasound is generally 
not recommended unless biochemical 
abnormalities are suggestive.3 However 
once localized, surgical resection is 
regarded as the therapy as choice as 
curative rates following removal approach 
90%.4 There have been multiple surgical 
approaches described in the literature for 
resection of insulinomas and pancreatic 
lesions.4 Choice of approach generally falls 
upon pre-operative imaging for precise 
localization and degree of respectability 
(i.e. vascular involvement). In the following 
report, we demonstrate how endoscopic 
ultrasound (EUS) with fine needle biopsy 
(FNB) can assist in both the diagnosis of a 
PNET and choice of surgical intervention.  
•  Insulinomas although rare, are the most common type of functional pancreatic neuroendocrine tumor
•  Diagnosis is typically made biochemically with intermittent recordings of the plasma levels of insulin, C-peptide, 
BHOB, and glucose during a fasting state (typically 72 hours)
•  Abdominal CT, magnetic resonance imaging, and ultrasound can detect most insulinomas5 however a negative 
scan prompts further investigation with more invasive diagnostic modalities
•  EUS with FNB has improved detection rates with classic findings of a round homogeneous, hypoechoic, mass 
with distinct margins7
   –  Atypical findings in our case
•  Curative treatment is achieved with surgical intervention of localized tumors8
•  Pending location, procedures may include typical resections with pancreaticoduodenectomy or distal 
pancreatectomy vs. atypical procedures with enucleation, partial pancreatectomy, or middle pancreatectomy4,8
•  If mass is not well capsulated, >4cm in diameter, involves or is near the pancreatic duct, or if multiple lesions 
are present, radical resection may be warranted7
•  In our report, it can be appreciated how EUS with FNB helped both support the diagnosis by presenting a pre-
operative histological diagnosis while offering radiological data to assist with surgical resection
DISCUSSION
A 53-year-old Hispanic female with an 8-year history of recurrent episodes of hypoglycemia, presented to the 
emergency room after being found obtunded. Finger-stick blood glucose was noted to be 58mg/dL and continuous 
glucose administration was required to keep her blood sugars stable. Shortly after her blood glucose stabilized, her 
symptoms and clinical state improved. She underwent further work-up with a 72 hour fasting analysis. However, due 
to poor compliance with frequent blood draws, this was discontinued. Her labs prior to discontinuation were significant 
and revealed an elevated insulin level of 38pmol/L, elevated C-peptide of 7.9ng/mL, and a low beta-hydroxybutyrate 
(BHOB) of 0.09mmol/L in the setting of serum plasma glucose of 48mg/dL. Thus indicating a hypersecretory pathway. 
Sulfonylurea screen and insulin antibodies were negative. An abdominal computed tomography (CT) scan with 
intravenous contrast was unremarkable. Additional imaging with abdominal magnetic resonance imaging (MRI) was 
performed revealing a lobulated contour of the pancreatic head with the possibility of an isointense mass (Figure 
1). Thus, EUS was utilized for further investigation exposing a 23mm x 24mm isoechoic pancreatic head mass with 
irregular borders without vascular involvement (Figure 2). FNB of the mass was positive for a pancreatic neoplasm 
with neuroendocrine features (Figure 3). Following localization with pathological support, surgical resection via 
pancreaticoduodenectomy (Whipple procedure) was performed. Pathologic analysis of the resected mass confirmed a 
PNET without evidence of malignancy. Following her procedure, her glucose levels normalized and she was discharged.  
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Figure 1: MRI Abdomen with IV contrast revealing a lobulated 
contour of the pancreatic head suggestive of an isointense mass. 
Figure 2: Endoscopic Ultrasound revealing an isoechoic pancreatic head mass with 
irregular borders.
Figure 3: Cytohistological analysis of fine needle biopsy obtained during EUS of pancreatic head mass noting 
uniform cohesive aggregates of uniform epithelial cells with eccentric nuclei.
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